MD862G2 - Средство для лечения и профилактики дислипидемии и атеросклероза - Google Patents

Средство для лечения и профилактики дислипидемии и атеросклероза

Info

Publication number
MD862G2
MD862G2 MD97-0168A MD970168A MD862G2 MD 862 G2 MD862 G2 MD 862G2 MD 970168 A MD970168 A MD 970168A MD 862 G2 MD862 G2 MD 862G2
Authority
MD
Moldova
Prior art keywords
dislipidemy
remedy
atherosclerosis treatment
pectine
increasing
Prior art date
Application number
MD97-0168A
Other languages
English (en)
Romanian (ro)
Other versions
MD862F1 (en
Inventor
Виктория ИВАНОВ
Надежда КРАСНОВА
Original Assignee
Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова filed Critical Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority to MD97-0168A priority Critical patent/MD862G2/ru
Publication of MD862F1 publication Critical patent/MD862F1/xx
Publication of MD862G2 publication Critical patent/MD862G2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к медицине, а именно к кардиологии.Сущность изобретения состоит в том, что средствo для лечения и профилактики дислипидемии и атеросклероза на основе полисахаридов включает пектин с уровнем этерификации выше 70%, с гипохолестеролемическим эффектом, который содержит катионы кальция в количестве 300-500 мг-экв./кг, в частности яблочный пектин.Техническим результатом изобретения является увеличение гипохолестеролемических свойств с уменьшением триглициридов и повышением уровня C-HDL.
MD97-0168A 1997-06-23 1997-06-23 Средство для лечения и профилактики дислипидемии и атеросклероза MD862G2 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD97-0168A MD862G2 (ru) 1997-06-23 1997-06-23 Средство для лечения и профилактики дислипидемии и атеросклероза

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD97-0168A MD862G2 (ru) 1997-06-23 1997-06-23 Средство для лечения и профилактики дислипидемии и атеросклероза

Publications (2)

Publication Number Publication Date
MD862F1 MD862F1 (en) 1997-10-31
MD862G2 true MD862G2 (ru) 1998-07-31

Family

ID=19739022

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0168A MD862G2 (ru) 1997-06-23 1997-06-23 Средство для лечения и профилактики дислипидемии и атеросклероза

Country Status (1)

Country Link
MD (1) MD862G2 (ru)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A.S. Truswell. " Dietary Fibre and Plasma Lipids: Potential for Prevention and Treatment of Hyperlipidaemias.Dietary Fibre-A component of food.1993.p.295-348. *
Cs. gastroenterologie, V.37,N1, E. Ginter, R. Kohn, A. Malovicova et al. " Zavislost. Hipolipemickeno ucinki pectinov na ich chemickom Zlozeni", p.37-46. *

Also Published As

Publication number Publication date
MD862F1 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
MXPA05001096A (es) Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina.
MX9705235A (es) Inhibidores de calpaina y/o catepsina b de oxazolidina substituida.
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
BG102726A (en) Combined therapy for osteoporosis
ATE397005T1 (de) Sialyl-lewisa und sialyl-lewisx epitope analoge
BG105556A (en) New esters derived from substituted phenyl-cyclohexyl compounds
IL110943A0 (en) Compositions for the treatment of skin disorders
HUP9700926A3 (en) Vitamine d3 analogues, process for producing them and pharmaceutial compositions containing the same
PL340561A1 (en) Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders
GB9300048D0 (en) Endothelin converting enzyme inhibitors
BG102818A (en) D-manitol and method for its preparation
SI0951909T2 (sl) Kombinirana zmes ki vsebuje L karnitin ali alkanoil L karnitin glikozaminoglikan in ali njegov sestavni del
EP0940316A3 (en) Drawer tower
MXPA04002565A (es) Combinacion de un inhibidor de il-1/18 con un inhibidor de tnf para el tratamiento de inflamacion.
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
AU121935S (en) Fully retractable captive screw
IL107736A0 (en) Triphostins and pharmaceutical compositions containing them
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
EP1275379A3 (en) Basic granulate comprising (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
IL148193A0 (en) Hard candy with improved storage stability
BR9812368A (pt) 2-aminotetralinas, processo para sua preparação, e composições farmacêuticas, para a prevenção e tratamento terapêutico de patologias inflamatórias e/ou autoimunes
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20170623

KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees